Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1994 Jan;120(Suppl 1):S23–S27. doi: 10.1007/BF01377119

7-Hydroxycoumarin inhibits oncogene-induced transformation of murine fibroblasts

R Seliger 1,✉, H Pettersson 2
PMCID: PMC12201256  PMID: 8132698

Abstract

7-Hydroxycoumarin (7-HC) is a naturally occuring substance with a variety of biological activities, e.g. antitumoral and immunomodulatory action. the potential mechanisms of 7-HC action on tumor cells have been investigated in a model of mouse fibroblasts transformed by distinet retroviral vectors carrying the oncogenesmyc andras. Treatment of the different oncogenic transformants with 7-HC in non-cytotoxic concentrations causes a strong inhibition of their proliferative capacity as measured by growth curves. Furthermore, incubation of theras andmyc transformants with 7-HC abrogated soft agar colony formation when compared to untreated cultures. These changes in cell growth characteristics of the various oncogene-transformed mouse fibroblasts were transient, since removal of 7-HC from the cultures caused a reappearance of the transformed properties of these cells within 6 days. The 7-HC-mediated inhibition of the proliferative capacity of the transformants was preceded by a selective down-regulation of oncogene expression. These data suggest that 7-HC causes a reversible inhibition ofras- andmyc-induced neoplastic properties in transformed fibroblasts by selective down-regulation of retroviral RNA levels.

Key words: 7-Hydroxycoumarin, Antitumoral activities, Oncogene, Transformation

Abbreviations

7-HC

7 hydroxycoumarin

References

  1. Chirgwin JM, Przybyla AA, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294 [DOI] [PubMed] [Google Scholar]
  2. Clemens M, McNurlan MA (1985) Regulation of cell proliferation and differentiation by interferon. J Biochem 226:345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colbère-Garapin F, Horodniceanu F, Kourilsky P, Garapin AC (1981) A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol 150:1 [DOI] [PubMed] [Google Scholar]
  4. Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD (1990) The pharmacology, metabolism, analysis and applications of coumarin and coumarin related compounds. Drug Metab Rev 22:503–529 [DOI] [PubMed] [Google Scholar]
  5. Einat M, Resnitzky D, Kimchi A (1985) Close link between reduction of c-myc expression by interferon and G0/G1. Nature 313:597 [DOI] [PubMed] [Google Scholar]
  6. Ellis DW, DeFeo D, Shin TY Gondon MA, Young HA, Tshusido N, Loxy DR, Scolnick ET (1981) The p21src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 292:506 [DOI] [PubMed] [Google Scholar]
  7. Friedman H (1981) Immunomodulating effect of cimetidine. In: Hersh EM, et al (eds) Augmenting agents in cancer therapy. Raven, New York, pp 417–425 [Google Scholar]
  8. Marshall ME, Mendelsohn L, Butler K, et al (1987) Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study. J Clin Oncol 5:862–866 [DOI] [PubMed] [Google Scholar]
  9. Marshall ME, Rhoades JL, Mattingly C, Jennings CD (1991) Coumarin (1,2-benzopyrone) enhances DR and DQ antigen expressions by peripheral blood mononuclear cells in vitro. Mol Biother 3:204–206 [PubMed] [Google Scholar]
  10. Marshall ME, Albany-Jenei S, Umerani A, Zhao Q (1993) Direct cytotoxic effects of coumarin and 7-hydroxycoumarin on human malignant cell lines in vitro. J Ir Coll Physicians Surg [Suppl] 22:71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moran E, Prosser E, Egan D, O'Kennedy R, Thornes RD (1993) The effect of coumarin and 7-hydroxycoumarin on the growth of human tumor cell lines. J Ir Coll Physicians Surg 22:41–43 [Google Scholar]
  12. Murray RDH, Mendex J, Brown SA (1982) The natural coumarins: occunence, chemistry and biochemistry Wiley, New York [Google Scholar]
  13. Ritschel WA, Hoffmann KA (1981) Pilot study on bioavailability of coumarin and 7-hydroxycoumarin in a sustained-release dosage form. J Clin Pharmacol 21:294–300 [DOI] [PubMed] [Google Scholar]
  14. Seliger B (1993) 7-Hydroxycoumarin mediated induction of differentiation of human malignant glioblastoma cells. J Ir Coll Physicians Surg [Suppl] 22:44–46 [Google Scholar]
  15. Seliger B, Kruppa B, Pfizenmaier K (1987) Murine gamma interferon inhibits v-mos induced fibroblast transformation via down-regulation of retroviral gene expression. J Virol 61:2567–2572 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Seliger B, Kruppa G, Schäfer R, Redmond S, Pfizenmaier K (1988) IFN-gamma regulates LTR-controlled oncogene expression in transformed mouse fibroblasts at the level of mRNA transcription. J Virol 62:619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stanton LW, Watt R, Marm KB (1983) Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature 303:401 [DOI] [PubMed] [Google Scholar]
  18. Thornes RD, Lynch G, Sheehan MV (1982) Cimetidine and coumarin therapy of melanoma Lancet II:328 [DOI] [PubMed] [Google Scholar]
  19. Tseng A (1993) Coumarin prevents tumorigenesis in MTV-Ha-ras transgenic animals. J Ir Coll Physicians Surg [Suppl] 22, 49–50 [Google Scholar]
  20. Tseng A, Snyder J, Lee WMF, Kirsten E (1987) Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly (ADP) ribose polymerase. Proc Natl Acad Sci USA 4:1107–1111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zänker KS (1993) Coumarins interface between cell growth inhibition, expression of oncogenes, tumor cell locomotion and cell-to-cell communication. J Ir Coll Physicians Surg [Suppl] 22:51–55 [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES